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Pace of medical research development heralded an 
escalation in recent years. Groundbreaking 
evidences have been provided for managing 
dyslipidemia in 2017. Beside statins, alternatives of 
Anti PCSK-9 monoclonal antibodies in human (1) 
and AT04A anti PCSK-9 vaccine (2) in mice have 
shown to significant decrease in total cholesterol 
level. Wonderful! 
Apart from this, dual pathway inhibition by using 
aspirin with very low dose Rivaroxaban has been 
shown to be more effective in mitigating ischemic 
event rate than aspirin alone in patients with stable 
coronary artery disease or peripheral artery 
disease (3). Furthermore, patients with atrial 
fibrillation undergo percutaneous coronary 
intervention will benefit more from double 
antithrombotic therapy than triple one (4, 5). 
Besides, a novel risk score of PRECISE-DAPT has 
determine the optimal duration of antiplatelet 
therapy in patients implanting coronary stents (6); 
and many other medical research advances which 
grabs our attention on 2018. 
 In order to translate recent advances in medical 
research into clinical practice we need to design, 
conduct and apply high quality research in 
different medical subspecialties. The emergency 
medicine (EM) environment defined as 
overburdened with inability to afford more than a 
few minutes per patients. Where, time for research 
might be considered as a potential risk of 
interruption in clinical practice. 
EM is a broad field involving multiple disciplines 
and crosscutting themes with the unique features 
in research including urgency and location of the 
treatment. Art of research in EM comprises 
hybridization of clinical research, basic science and 
health services research. Accordingly, research 
priority setting should be put forwarded based on 
these three areas, examining existing gaps in EM 
knowledge, system design issues, educational 
predicament and disparities between diagnostic 
skills and clinical decisions (7-9).   
Where the most appropriate research questions 
arise? Definitely, it comes from critical thinking in 
patient care setting, regular reading habit, 
teaching, journal clubs, collaborations and society. 
To alleviate the issue of immense question and 
limited time in EM field which tangles decision 
makers mind we recommend to prioritize 
questions in line with; patients well- being, 
learners need, feasibility to answer, inquiries that 
most likely to recur in your practice and most 
interesting foreground research query.  
A research need has been defined as a gap in 
existing knowledge on practice, learner‚s 
education, patient values and societal demands. To 
examine the gaps in EM research knowledge we 
can provide research time and facilities, training 
new investigators, develop multicenter research 
networks, improve research coordination and 
involving funding agencies to make practical 
attempts for filling pre specified gaps (10, 11).  
In conclusion, since patient oriented outcome 
research will provide us with the most important 
endpoints for clinical policy making and patient 
care standard setting, I totally agree with the 
advocates of involving stakeholders including 
clinicians, society and patients in EM research 
process to mitigate the existence knowledge gaps 
for dedicating high quality EM care. 
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